Inventor · disambiguated record
Louis M. Staudt
Also filed as: STAUDT LOUIS · STAUDT LOUIS M · STAUDT LOUIS MICHAEL
17 granted patents·12 pending applications·386 citations·filing 1995–2023
93Inventor score
Top patents by PatentIndex Score
29 records- 0191US6410516B1Nuclear factors associated with transcriptional regulationHARVARD COLLEGE·Filed 1995·Granted Jun 25, 2002·167 cites·203 claims
- 0289US7711492B2Methods for diagnosing lymphoma typesUS HEALTH·Filed 2004·Granted May 4, 2010·29 cites·29 claims
- 0387US6150090ANuclear factors associated with transcriptional regulationMASSACHUSETTS INST TECHNOLOGY·Filed 1995·Granted Nov 21, 2000·69 cites·24 claims
- 0486US7329502B2ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)US HEALTH·Filed 2002·Granted Feb 12, 2008·22 cites·14 claims
- 0583US10607717B2Method for subtyping lymphoma types by means of expression profilingUS HEALTH·Filed 2014·Granted Mar 31, 2020·4 cites·3 claims
- 0683US8131475B2Methods for identifying, diagnosing, and predicting survival of lymphomasSTAUDT LOUIS M·Filed 2006·Granted Mar 6, 2012·10 cites·6 claims
- 0783US5804374ANuclear factors associates with transcriptional regulationMASSACHUSETTS INSTI TECHNOLOGY·Filed 1995·Granted Sep 8, 1998·82 cites·5 claims
- 0883US2024065971A1Methods of treating abc-dlbcl using inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 0980US7981610B2ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)US HEALTH·Filed 2007·Granted Jul 19, 2011·2 cites·10 claims
- 1070US10370715B2Methods for identifying, diagnosing, and predicting survival of lymphomasUS HEALTH·Filed 2014·Granted Aug 6, 2019·1 cites·5 claims
- 1169US2020246259A1Methods of treating abc-dlbcl using inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 1268US2018311153A1Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1363US11028444B2Survival predictor for diffuse large B cell lymphomaUS HEALTH·Filed 2018·Granted Jun 8, 2021·0 cites·4 claims
- 1463US2016243033A1Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Application pending·0 cites
- 1563US2025283177A1Biomarkers and methods of use thereof for treatment of peripheral t-cell lymphomaUNIV NEBRASKA·Filed 2023·Application pending·0 cites
- 1662US2012071497A1Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinaseBUGGY JOSEPH J·Filed 2011·Application pending·0 cites
- 1760US2012225793A1Methods for identifying, diagnosing, and predicting survival of lymphomasSTAUDT LOUIS M·Filed 2012·Application pending·0 cites
- 1859US8748114B2ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)STAUDT LOUIS M·Filed 2011·Granted Jun 10, 2014·0 cites·20 claims
- 1958US2006063709A1Nuclear factors associated with transcriptional regulationBALTIMORE DAVID·Filed 2002·Application pending·0 cites
- 2058US2011195064A1Survival predictor for diffuse large b cell lymphomaUS HEALTH·Filed 2009·Application pending·0 cites
- 2157US11574704B2Method for subtyping lymphoma types by means of expression profilingUS HEALTH·Filed 2020·Granted Feb 7, 2023·0 cites·12 claims
- 2257US10697975B2Methods for identifying, diagnosing, and predicting survival of lymphomasUS HEALTH·Filed 2017·Granted Jun 30, 2020·0 cites·5 claims
- 2357US9970059B2Survival predictor for diffuse large B cell lymphomaUS HEALTH·Filed 2014·Granted May 15, 2018·0 cites·16 claims
- 2455US2007237717A1Methods for Selection of Subjects for Multiple Sclerosis TherapyMARTIN ROLAND·Filed 2004·Application pending·0 cites
- 2555US2004214757A1Nuclear factors associated with transcriptional regulationFiled 2002·Application pending·0 cites
- 2650US11646099B2Method for determining lymphoma type and providing treatmentUS HEALTH·Filed 2019·Granted May 9, 2023·0 cites·7 claims
- 2750US9783586B2Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methodsUS HEALTH·Filed 2014·Granted Oct 10, 2017·0 cites·40 claims
- 2848US2011152115A1Methods for identifying, diagnosing, and predicting survival of lymphomasUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND·Filed 2011·Application pending·0 cites
- 2939US11725248B2Evaluation of mantle cell lymphoma and methods related theretoUS HEALTH·Filed 2017·Granted Aug 15, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Louis M. Staudt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →